Treatment of Limited-Stage Small Cell Lung Cancer in the Elderly, Chemotherapy vs. Sequential Chemoradiotherapy vs. Concurrent Chemoradiotherapy: That’s the Question

Translational Lung Cancer Research- Hong Kong

doi 10.21037/tlcr.2016.03.03

Full Text

Abstract

Available in

Date

April 1, 2016

Authors

Publisher

AME Publishing Company

Related search

Preoperative Concurrent Chemoradiotherapy for Stage IIIA Non-Small Cell Lung Cancer

English

Is Concurrent Chemoradiotherapy Also the Best Treatment for Elderly Patients With Limited-Stage Small Cell Lung Cancer? – What the CONVERT Data Can Tell Us

Journal of Thoracic Oncology

English

Phase II Study of Consolidation Amrubicin After Concurrent Chemoradiotherapy in Patients With Limited-Stage Small-Cell Lung Cancer

English

Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer

English

Concurrent Chemoradiation in Elderly Patients With Limited-Stage Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer

Frontiers in Oncology

Cancer Research

Oncology

2017

English

Comparison of Concurrent Chemoradiotherapy Versus Sequential Radiochemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer

Radiation Oncology Journal

English

P2.17-05 Consolidation Chemotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer After Concurrent Chemoradiotherapy

Journal of Thoracic Oncology

English

P2.17-21 Efficacy of Concurrent Carboplatin-Paclitaxel Chemoradiotherapy With 66 Gy for Elderly Patients With Stage III Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Amanote Research

Treatment of Limited-Stage Small Cell Lung Cancer in the Elderly, Chemotherapy vs. Sequential Chemoradiotherapy vs. Concurrent Chemoradiotherapy: That’s the Question

Translational Lung Cancer Research- Hong Kong

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Preoperative Concurrent Chemoradiotherapy for Stage IIIA Non-Small Cell Lung Cancer

Is Concurrent Chemoradiotherapy Also the Best Treatment for Elderly Patients With Limited-Stage Small Cell Lung Cancer? – What the CONVERT Data Can Tell Us

Phase II Study of Consolidation Amrubicin After Concurrent Chemoradiotherapy in Patients With Limited-Stage Small-Cell Lung Cancer

Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer

Concurrent Chemoradiation in Elderly Patients With Limited-Stage Small Cell Lung Cancer

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer

Comparison of Concurrent Chemoradiotherapy Versus Sequential Radiochemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer

P2.17-05 Consolidation Chemotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer After Concurrent Chemoradiotherapy

P2.17-21 Efficacy of Concurrent Carboplatin-Paclitaxel Chemoradiotherapy With 66 Gy for Elderly Patients With Stage III Non-Small Cell Lung Cancer